Kuo, P., Hesterman, J., Rahbar, K., Kendi, A. T., Wei, X. X., Fang, B., … Vogelzang, N. J. (2022). [⁶⁸Ga]Ga-PSMA-11 PET baseline imaging as a prognostic tool for clinical outcomes to [¹⁷⁷Lu]Lu-PSMA-617 in patients with mCRPC: A VISION substudy. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40).

Kuo, Phillip, Jacob Hesterman, Kambiz Rahbar, Ayse T. Kendi, Xiao X. Wei, Bruno Fang, Nabil Adra, et al. “[⁶⁸Ga]Ga-PSMA-11 PET baseline imaging as a prognostic tool for clinical outcomes to [¹⁷⁷Lu]Lu-PSMA-617 in patients with mCRPC: A VISION substudy.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 40, 2022.

Kuo P, Hesterman J, Rahbar K, Kendi AT, Wei XX, Fang B, et al. [⁶⁸Ga]Ga-PSMA-11 PET baseline imaging as a prognostic tool for clinical outcomes to [¹⁷⁷Lu]Lu-PSMA-617 in patients with mCRPC: A VISION substudy. In: JOURNAL OF CLINICAL ONCOLOGY. 2022.

Kuo, Phillip, et al. “[⁶⁸Ga]Ga-PSMA-11 PET baseline imaging as a prognostic tool for clinical outcomes to [¹⁷⁷Lu]Lu-PSMA-617 in patients with mCRPC: A VISION substudy.” JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022.

Kuo P, Hesterman J, Rahbar K, Kendi AT, Wei XX, Fang B, Adra N, Armstrong AJ, Garje R, Michalski JM, Ghebremariam S, Brackman M, Wong C, Benson T, Vogelzang NJ. [⁶⁸Ga]Ga-PSMA-11 PET baseline imaging as a prognostic tool for clinical outcomes to [¹⁷⁷Lu]Lu-PSMA-617 in patients with mCRPC: A VISION substudy. JOURNAL OF CLINICAL ONCOLOGY. 2022.